Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Op-Eds
Clone: It’s What’s for Dinner
SAN FRANCISCO — California politics lately seems a parody of itself. Starting in February, San Francisco will become the first city in the country…
News Release
New Physician Survey Finds FDA Too Slow in Approving New Drugs and Devices
Contacts: Sam Kazman, CEI, 202.331.2265 Kellyanne Conway, the polling company, 202.667.6557 Dr. Robert Nirschl, orthopedic surgeon, 703-525-2200, x102 Washington, D.C.,…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. BUSINESS Competitors renew complaints about the dominance of Microsoft as the company prepares…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ENVIRONMENT International security analysts predict that climate change could exacerbate violent conflicts around the world.
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CONGRESS President Bush prepares to deliver his State of the Union address before…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CONGRESS The House of Representative approves legislation requiring the government to negotiate lower…